Marinus Pharmaceuticals reported $2.34M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US USD 130.71M 3.85M
ALKERMES ALKS:US USD 252.36M 23.86M
Amgen AMGN:US USD 6.84B 187M
Biogen BIIB:US USD 2.51B 80.6M
Enanta Pharmaceuticals ENTA:US USD 20.32M 838K
Esperion Therapeutics ESPR:US USD 18.98M 139K
Gilead Sciences GILD:US USD 7.39B 347M
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Intra Cellular Therapies ITCI:US USD 71.87M 16.29M
Marinus Pharmaceuticals MRNS:US USD 2.34M 550K
Ptc Therapeutics PTCT:US USD 217.13M 51.6M
Regeneron Pharmaceuticals REGN:US USD 3.41B 478.2M
Sarepta Therapeutics SRPT:US USD 230.27M 3.22M
Supernus Pharmaceuticals SUPN:US USD 177.35M 7.3M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M
YTE INCY:US USD 823.3M 88.09M